Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 28.33M 31.89M 26.45M 24.1M 45.46M 3.07B 45.88M 320M 124M 1.57B 120M 117M 5.03B | P/E 2026 * |
-6.43x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 28.33M 31.89M 26.45M 24.1M 45.46M 3.07B 45.88M 320M 124M 1.57B 120M 117M 5.03B | EV / Sales 2026 * |
9.44x | EV / Sales 2027 * | 2.83x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Emmet Purtill
PRN | Corporate Officer/Principal | - | 01/01/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 31.89M | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -1.01% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | +0.42% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.38M 2.8M 2.55M 4.81M 325M 4.86M 33.89M 13.13M 166M 12.68M 12.4M 533M | 10M 11.25M 9.33M 8.51M 16.04M 1.08B 16.19M 113M 43.77M 553M 42.26M 41.34M 1.78B |
| Net income | -5M -5.63M -4.67M -4.25M -8.02M -541M -8.1M -56.48M -21.88M -277M -21.13M -20.67M -888M | 2M 2.25M 1.87M 1.7M 3.21M 216M 3.24M 22.59M 8.75M 111M 8.45M 8.27M 355M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
